Viviana Regina Konzen

Viviana Regina Konzen

Auto-generated profile, based on publicly available information

Viviana Regina Konzen

Universidade Federal do Rio Grande do Sul, Brazil; Hospital de Clínicas de Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Radiologia Brasileira
Verified
Journal Article
Open access
VKViviana Regina Konzen
Viviana Regina Konzen
AFAlessandro Finkelsztejn
Alessandro Finkelsztejn
RSRaquel Prates dos Santos
Raquel Prates dos Santos
ASAdolfo Moraes de Souza
Adolfo Moraes de Souza
MRMatheus de Lima Ruffini
Matheus de Lima Ruffini
JDJuliana Ávila Duarte
Juliana Ávila Duarte
Objective: This study aimed to assess whether the evaluation of the central vein sign (CVS) and paramagnetic rim lesions (PRLs) using susceptibility-weighted magnetic resonance imaging (MRI) can distinguish multiple sclerosis (MS) from migraine. Materials and Methods: In this single-center observational study, we conducted a cross-sectional analysis of the CVS, determining the proportion of CVS-positive lesions per individual and absolute counts, using thresholds of 3 lesions (select3*) and 6 lesions (select6*), and of PRLs in participants with MS and in those with migraine, from 3.0-T MRI brain scans. Results: The study included 20 participants with MS, 20 with migraine, and 20 included as healthy controls. The proportion of participants with CVS-positive lesions was higher in the MS group than in the migraine group (61.8% vs. 10.4%), and PRLs were observed exclusively in the MS group. The presence of at least one PRL and the select6* criterion demonstrated the highest diagnostic accuracy within the study sample. Conclusion: The detection of the CVS and of a PRL on 3.0-T MRI scans may serve as a reliable biomarker to differentiate MS from migraine.

1 January 2024 in Clinical and Biomedical Research
Verified
Journal Article
Open access
PDF file
GNGiovani Noll
Giovani Noll
TSTahiane de Brum Soares
Tahiane de Brum Soares
JDJuliana Avila Duarte
Juliana Avila Duarte
MMMatheus Bernardon Morillos
Matheus Bernardon Morillos
FSFernando Augusto Marion Spengler
Fernando Augusto Marion Spengler
JSJonas Alex Morales Saute
Jonas Alex Morales Saute
Introduction: Multiple sclerosis may rarely present alongside idiopathic thrombocytopenic purpura and scarcely ever following splenectomy for hematologic disease. Methods and Results: We report the case of a 51-year-old woman presenting with subacute onset of mild ataxia, dysarthria and lower limb dysesthesia in close temporal relationship with splenectomy performed as a treatment for steroid-dependent idiopathic thrombocytopenic purpura. MRI showed hyperintense T2/FLAIR multifocal white-matter lesions and there were highly positive cerebrospinal-fluid oligoclonal bands, picturing her first clinical episode of multiple sclerosis. She was treated with intravenous methylprednisolone, with significant improvement, and then started on multiple sclerosis disease-modifying therapy. Conclusion: This report suggests the possible role of splenectomy as an environmental trigger for clinical multiple sclerosis in genetically predisposed individuals, as well as for those with radiologically isolated syndrome. Introdução: A esclerose múltipla pode raramente apresentar-se em concomitância com a púrpura trombocitopênica idiopática e, excepcionalmente, após esplenectomia por doença hematológica. Métodos e Resultados: Relatamos o caso de uma mulher de 51 anos que apresentou início subagudo de ataxia leve, disartria e disestesia de membros inferiores em estreita relação temporal com esplenectomia realizada como tratamento para púrpura trombocitopênica idiopática cortico-dependente. A ressonância magnética mostrou lesões multifocais hiperintensas na substância branca em T2/FLAIR e foi evidenciada a presença de bandas oligoclonais exclusivas no líquor, caracterizando seu primeiro surto clínico de esclerose múltipla. Foi tratada com metilprednisolona intravenosa, com melhora significativa, e posteriormente submetida a terapia modificadora da doença para esclerose múltipla. Conclusão: Este relato de caso sugere o possível papel da esplenectomia como gatilho para o desencadeamento de esclerose múltipla clinicamente manifesta em indivíduos geneticamente predispostos, bem como para aqueles com síndrome radiologicamente isolada.